Skip to main content

Mhealth - Counterfeit Drugs India

WHO tells a story “By April 1999, reports of 771 cases of substandard drugs had been entered into the WHO database on counterfeit drugs, 77% of which were from developing countries. (Data analysis showed that in 60% of the 325 cases for which detailed data were available, an active ingredient was lacking.)”

Bad medicines don't just threaten lives; they undermine the entire medical system.

What is being done?

There are distinct aspects to deciphering and de-complexifying the counterfeit pharmaceutical supply chain. One that is probably more in use today by almost all pharmaceutical companies worldwide is the product-based tracking methodology which incorporates the use of high technology systems to identify counterfeit products in the market. These technologies include tamper-evident packaging, holographics, bar codes and the more recent RFID.

Indian Scenario

People buy two tablets and never a strip. The unique number idea doesn’t work here.

Chemists know that they are buying counterfeit drugs- they get better margins on them.

Chemists don’t want to find out whether they are selling counterfeit drugs?- Barcode thing doesn’t work here. Same stuff with hologram and all.

Interventions are required at the distributor level or best at the consumer level.

Roger Bate says “According to an investigation I just conducted with the Legatum Institute and the International Policy Network, the situation is as bad with at least some of Delhi's wholesalers. We found that 7% of all tested samples were substandard and 3.6% were likely counterfeit. It's probable that the drug supply in poorer areas is even more contaminated.











A strong majority of Indian pharmacists interviewed in our investigation admit that fellow pharmacists knowingly profit from the sale of counterfeit drugs. Nearly all of the pharmacists interviewed claimed to have been propositioned by counterfeiters at one time or another. Last year alone, counterfeit drugs were seized by authorities in Bangalore, Mumbai, Delhi, Jaipur and many other Indian cities. In 2008, about half of the medical products that were confiscated by European Union customs officials originated in India.

I believe in Simplicity….

Solutions should be uncomplicated - According to a study published by researchers of the University of Lleida (UdL) in the scientific journal Sensors, the sensor of some optical mice can be used to easily and cheaply detect counterfeit euros – Something like this for Drugs packaging can be great!!! http://www.sciencedaily.com/releases/2009/11/091117094935.htm

Or;

If we really have to go that precise in judging counterfeit and fake drugs, there is a specific way out for which testing centers can be set up. We all know about Raman spectroscopy- I know it from our chemistry labs. The investigators describe development of a new form of Raman spectroscopy, a mainstay tool for identifying molecules, which can probe deep layers of material that are well beyond the reach of conventional Raman spectroscopy. The method, spatially offset Raman spectroscopy, can analyze through paper packaging, plastic containers, capsule shells, and tablet coatings to verify the ingredients in a pharmaceutical product, the researcher’s state. http://www.sciencedaily.com/releases/2007/01/070129140741.htm

Innovative Transponders-The Radiopharm Project -The most innovative is the tagging of transponders on item-level (incl. write and read processes), not only on case or pallet level. It was aimed to get an identification of every single transponder, despite the disturbing influences of liquids and metals. This requirement creates new challenges, especially for the RFID technology that occurs in the pharmaceutical area. The co-workers of the IFT built a test rig for multiple test scenarios as a demonstrator to proof the technical realization of the developed system.

With this test rig, it can be determined if the transponders could be reliably accessed independent from the dosage form (like liquids, tablets, ointments), both for item identification and bulk identification. As a result, it is possible not only to illustrate a production line of a pharmaceutical manufacturer, but also the verification process after order picking at the wholesaler. By the use of these systems customers will have a higher security when buying drugs.


In the SWOT analysis of Big Pharma majors, Counterfeit was reflected as a common problem. I just finished working on a Counterfeit drug detection model. Cost per counterfeit drug test Rs 1 only.

Interested Companies/researchers can reach me at drruchibhatt@gmail.com.

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki